Vesilute 20 mg

Vesilute is a short peptide bioregulator developed within the Khavinson-school tradition of low-molecular-weight peptide research. It is classified as a tissue-specific bioregulator with reported affinity for urinary tract and bladder epithelial research models. Vesilute is part of a broader family of short peptides studied for their influence on tissue-specific gene expression in laboratory settings.

At the molecular level, Vesilute is investigated for its proposed role as a transcriptional modulator. Short peptide bioregulators of this class are studied for their ability to interact with promoter regions of DNA and influence the expression of genes involved in cellular turnover, differentiation, and tissue homeostasis. In urinary epithelial research models, Vesilute is examined for its influence on markers of epithelial renewal and stress adaptation under controlled in vitro conditions.

Vesilute is studied within research programs focused on tissue-renewal biology, urinary epithelial physiology, and age-associated changes in genitourinary tract research models. Khavinson-school investigations have characterized this and related short-peptide bioregulators as research tools for studying tissue-specific gene-expression patterns and cellular-turnover dynamics (Khavinson and Anisimov, 2009, Advances in Gerontology). Research interest continues in comparative studies that examine bioregulator peptides across multiple tissue-research contexts.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The short-peptide bioregulator framework was developed at the Saint Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson and colleagues. Beginning in the 1970s, this research program characterized tissue extracts from various organs and progressively isolated short peptide fragments that appeared to influence gene-expression patterns within their tissue of origin. Vesilute belongs to this lineage of tissue-derived short peptides, with a research focus on urinary tract and bladder biology.

Research on Khavinson-school bioregulators expanded throughout the 1990s and 2000s, with multiple publications proposing that di-, tri-, and tetra-peptide sequences can interact with DNA promoter regions in a sequence-selective manner. This model positions short peptide bioregulators as research tools for studying tissue-specific transcriptional programs in cell-culture and animal-model systems. Vesilute is referenced in this context as a urinary-system-directed compound.

Vesilute occupies a defined position within the Pepcore bioregulator catalog as a research tool for urinary epithelial and bladder-tissue investigations. It is typically studied in parallel with other organ-directed bioregulators in cell-culture and gene-expression research workflows, supporting comparative analysis across the bioregulator family.

1. Sequence-Selective DNA Interaction

Vesilute is studied within the Khavinson-school framework that proposes short peptide bioregulators interact directly with DNA in a sequence-selective manner. In this research model, short peptides are examined for their ability to bind specific regions within promoter sequences and influence transcriptional initiation in cultured cell systems and tissue-extract preparations.

2. Tissue-Specific Gene Expression Modulation

In urinary epithelial research models, Vesilute is investigated for its influence on gene-expression patterns associated with epithelial cell turnover, barrier-function biology, and stress-response signaling. Research designs typically use cultured bladder or urothelial cell lines to characterize expression changes under controlled laboratory conditions.

3. Cellular Renewal and Differentiation Research

Vesilute is examined for its influence on proliferation and differentiation markers in urinary tract research models. Investigations focus on standard biomarkers of epithelial renewal, including cytokeratin profiles, junctional proteins, and proliferation indices, providing a quantitative framework for evaluating peptide influence on tissue-renewal pathways.

4. Comparative Bioregulator Profiling

Within the bioregulator research family, Vesilute is studied alongside organ-directed peers such as Prostamax, Crystagen, and Cartalax. Comparative profiling examines the specificity of each peptide for its proposed target tissue, contributing to the broader research framework that supports the tissue-specificity hypothesis of short peptide bioregulators.

Research Applications

Conclusion

Vesilute is a short peptide bioregulator positioned within the Khavinson-school tradition of tissue-directed peptide research. It is studied for its proposed influence on urinary epithelial gene expression and tissue-renewal research models. Continued comparative work across the bioregulator family supports its use as a research tool in laboratories investigating tissue-specific transcriptional biology.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.